Press Releases

ABBOTT PARK, Ill., Feb. 18, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for the new Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, bringing the most advanced heart rhythm management capabilities along with a new set of benefits to people in Europe with a

GÖTTINGEN, Germany, Feb. 18, 2020 /PRNewswire/ -- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, confirmed its preliminary figures upon publication of its 2019 Annual Report today.

HERTFORDSHIRE, England and PITTSBURGH, Feb. 18, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its

IRVINE, Calif., Feb. 18, 2020 /PRNewswire/ -- Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of Benjamin Oyler as Chief Operating Officer. He will lead Laboratory for Advanced Medicine's global business opera

HOUSTON, Feb. 18, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced the final data from its CTCL clinical trial of WP1220 for the treatment of cutaneous T-cell lymphoma (CTCL), which was published and

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- As the novel coronavirus outbreak in Wuhan spreads, Sunon Charity Foundation acted quickly and in unity to fight against this disease. On January 28, Sunon provided an initial $1.43million to relief and

SAN DIEGO, Feb. 18, 2020 /PRNewswire/ -- Nucleus Biologics, a leader in precision cell culture, announced today a complete line of cGMP grade media and a new supplement to enable improved insulin response and standardized processing of human pancreatic islets and beta cells.

DUBLIN, Feb. 18, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast Management presentations:

HOUSTON, Feb. 18, 2020 /PRNewswire/ -- 

Patients Can Now Use Site to Consult with Qualified Health Care Professionals On-Demand, Order and Potentially Receive Dermatologist-Recommended Skin Care Products BRIDGEWATER, N.J., Feb. 18, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology heal